News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Robichaud Albert
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/07/2023 |
4
| Robichaud Albert (Chief Scientific Officer) has filed a Form 4 on Sage Therapeutics, Inc.|
Txns:
| Granted 3,375 shares
@ $0
Paid exercise price by delivering 1,127 shares
@ $44.16, valued at
$49.8k
|
|
| 02/15/2022 |
4
| Robichaud Albert (Chief Scientific Officer) has filed a Form 4 on Sage Therapeutics, Inc.|
Txns:
| Granted 13,300 options to buy
@ $43.04, valued at
$572.4k
|
|
| 10/21/2021 |
4
| Robichaud Albert (Chief Scientific Officer) has filed a Form 4 on Sage Therapeutics, Inc.|
Txns:
| Granted 3,800 shares
@ $0
Paid exercise price by delivering 1,116 shares
@ $40.29, valued at
$45k
|
|
| 06/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/30/2020 |
4
| Robichaud Albert (Chief Scientific Officer) has filed a Form 4 on Sage Therapeutics, Inc.|
Txns:
| Granted 9,450 options to buy
@ $39.87, valued at
$376.8k
|
|
| 02/14/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/10/2019 |
4
| Robichaud Albert (Chief Scientific Officer) has filed a Form 4 on Sage Therapeutics, Inc.|
Txns:
| Bought 25,000 shares
@ $64.16, valued at
$1.6M
Exercised 6,935 options to buy
@ $1.36, valued at
$9.4k
Exercised 5,732 options to buy
@ $38.25, valued at
$219.2k
Exercised 3,076 options to buy
@ $28.63, valued at
$88.1k
|
|
| 07/29/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/25/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/15/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/14/2019 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities: |
| 12/11/2018 |
4
| Robichaud Albert (Chief Scientific Officer) has filed a Form 4 on Sage Therapeutics, Inc.|
Txns:
| Granted 6,600 options to buy
@ $47.7, valued at
$314.8k
|
|
| 04/04/2018 |
4
| Robichaud Albert (Chief Scientific Officer) has filed a Form 4 on Sage Therapeutics, Inc.|
Txns:
| Granted 31,500 options to buy
@ $145.77, valued at
$4.6M
|
|
| 12/14/2017 |
4
| Robichaud Albert (Chief Scientific Officer) has filed a Form 4 on Sage Therapeutics, Inc.|
Txns:
| Sold 1,500 shares
@ $156.31, valued at
$234.5k
Sold 3,700 shares
@ $157.27, valued at
$581.9k
Sold 16,748 shares
@ $158.18, valued at
$2.6M
Sold 8,734 shares
@ $159.46, valued at
$1.4M
Sold 21,410 shares
@ $160.12, valued at
$3.4M
Sold 6,187 shares
@ $161.4, valued at
$998.6k
Sold 700 shares
@ $162.21, valued at
$113.5k
Sold 1,021 shares
@ $163.93, valued at
$167.4k
|
|
| 02/08/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/16/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/01/2016 |
4
| Robichaud Albert (Chief Scientific Officer) has filed a Form 4 on Sage Therapeutics, Inc.|
Txns:
| Exercised 15,287 options to buy
@ $1.36, valued at
$20.8k
|
|
| 07/14/2016 |
4
| Robichaud Albert (Chief Scientific Officer) has filed a Form 4 on Sage Therapeutics, Inc.|
Txns:
| Sold 22,000 shares
@ $40, valued at
$880k
|
|
| 02/10/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|